Jan Mattsson

2.1k total citations
43 papers, 1.4k citations indexed

About

Jan Mattsson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jan Mattsson has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Jan Mattsson's work include Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (8 papers) and Immunotherapy and Immune Responses (8 papers). Jan Mattsson is often cited by papers focused on Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (8 papers) and Immunotherapy and Immune Responses (8 papers). Jan Mattsson collaborates with scholars based in Sweden, United Kingdom and Denmark. Jan Mattsson's co-authors include Roger Olofsson Bagge, Per Lindnér, Carl‐Magnus Rudenstam, E. Cahlin, Halvard Lingaas, Stellan Persson, Nils Bjurstam, Stephen W. Duffy, Larsolof Hafström and Lena Björneld and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Jan Mattsson

43 papers receiving 1.3k citations

Peers

Jan Mattsson
P Bertheau France
Nancy Bouvier United States
Janice Patterson United States
Neerav Shukla United States
Luc Cabel France
Jan Mattsson
Citations per year, relative to Jan Mattsson Jan Mattsson (= 1×) peers E. Kumpulainen

Countries citing papers authored by Jan Mattsson

Since Specialization
Citations

This map shows the geographic impact of Jan Mattsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Mattsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Mattsson more than expected).

Fields of papers citing papers by Jan Mattsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Mattsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Mattsson. The network helps show where Jan Mattsson may publish in the future.

Co-authorship network of co-authors of Jan Mattsson

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Mattsson. A scholar is included among the top collaborators of Jan Mattsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Mattsson. Jan Mattsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagge, Roger Olofsson, Charlotta All‐Eriksson, Christian Cahlin, et al.. (2024). Survival and Quality of Life After Isolated Hepatic Perfusion With Melphalan as a Treatment for Uveal Melanoma Liver Metastases. Annals of Surgery. 282(1). 100–107. 7 indexed citations
2.
Bagge, Roger Olofsson, Charlotta All‐Eriksson, Christian Cahlin, et al.. (2023). Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial). Journal of Clinical Oncology. 41(16). 3042–3050. 33 indexed citations
4.
Johansson, Iva, Dennie Tempel, Jvalini Dwarkasing, et al.. (2021). Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary. European Journal of Surgical Oncology. 48(2). 320–325. 27 indexed citations
5.
Belgrano, Valerio, et al.. (2019). Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma. Annals of Surgical Oncology. 26(4). 1055–1062. 10 indexed citations
8.
Killander, Fredrika, Per Karlsson, H. Anderson, et al.. (2016). No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT. European Journal of Cancer. 67. 57–65. 48 indexed citations
9.
Hansson, Christoffer, Malin Sternby Eilard, Christian Cahlin, et al.. (2015). Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma. Journal of Visualized Experiments. 52490–52490. 18 indexed citations
10.
Eldh, Maria, Roger Olofsson Bagge, Cecilia Lässer, et al.. (2014). MicroRNA in exosomes isolated directly from the liver circulation in patients with metastatic uveal melanoma. BMC Cancer. 14(1). 962–962. 90 indexed citations
11.
Bagge, Roger Olofsson, Erika Lindberg, Alex Karlsson‐Parra, et al.. (2013). Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma. International Journal of Hyperthermia. 29(3). 234–238. 18 indexed citations
12.
Bagge, Roger Olofsson, Jan Mattsson, & Per Lindnér. (2013). Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma. International Journal of Hyperthermia. 29(6). 551–557. 42 indexed citations
13.
Bagge, Roger Olofsson, Peter Bergh, Ö. Berlin, et al.. (2012). Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the Extremity. Annals of Surgical Oncology. 19(6). 1800–1807. 12 indexed citations
14.
Mattsson, Jan, Leif Bergkvist, Avni Abdiu, et al.. (2008). Sentinel node biopsy in malignant melanoma: Swedish experiences 1997–2005. Acta Oncologica. 47(8). 1519–1525. 16 indexed citations
15.
Bjurstam, Nils, Lena Björneld, Jane Warwick, et al.. (2003). The Gothenburg Breast Screening Trial. Cancer. 97(10). 2387–2396. 210 indexed citations
16.
Malmström, Annika, Lars Holmberg, H. Anderson, et al.. (2003). Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. European Journal of Cancer. 39(12). 1690–1697. 125 indexed citations
17.
Lindnér, Per, M Fjälling, L Hafström, et al.. (1999). Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. European Journal of Surgical Oncology. 25(2). 179–185. 36 indexed citations
18.
Jungnelius, Ulf, Ulrik Ringborg, Jan Mattsson, et al.. (1998). Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial. European Journal of Cancer. 34(9). 1368–1374. 39 indexed citations
19.
Hafström, Larsolof & Jan Mattsson. (1993). Regional chemotherapy for malignant melanoma. Cancer Treatment Reviews. 19(1). 17–28. 13 indexed citations
20.
Mattsson, Jan, L. Appelgren, Bertil Hamberger, & H.-I. Peterson. (1977). Adrenergic innervation of tumour blood vessels. Cancer Letters. 3. 347–351. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026